Juan José Dapueto1, María del Carmen Abreu2, Carla Francolino2, Roberto Levin3. 1. Department of Medical Psychology, Faculty of Medicine, University of the Republic, Montevideo, Uruguay. Electronic address: jdapueto@hc.edu.uy. 2. Department of Medical Psychology, Faculty of Medicine, University of the Republic, Montevideo, Uruguay. 3. Palliative Care Unit, Department of Clinical Oncology, Faculty of Medicine, University of the Republic School of Medicine, Montevideo, Uruguay; State Administration of Health Services, Montevideo, Uruguay.
Abstract
CONTEXT: Several instruments have been developed to assess the symptom burden and fatigue produced by cancer and its treatment. However, little research has been conducted in Latin American Spanish-speaking patients. OBJECTIVES: The aim of the study was to assess the psychometric properties of the Spanish versions of two commonly used patient-reported outcome measures, the Memorial Symptom Assessment Scale-Short Form (MSAS-SF), and the fatigue subscale of the Functional Assessment of Cancer Therapy-General (FACT-G), the FACIT-Fatigue. METHODS: A classic psychometric approach was followed to assess the reliability and validity of the instruments. Responsiveness to change and effect sizes were calculated. RESULTS: The translated version of the MSAS-SF proved to be comprehensible and easy to complete. Cronbach alpha reliability coefficients ranged from acceptable to excellent for the MSAS-SF subscale scores and the FACIT-Fatigue. There was evidence of convergent validity between the physical and the psychological subscales of the instruments. The MSAS-SF could discriminate among the known groups according to Eastern Cooperative Oncology performance status and level of anemia, and showed responsiveness to change of symptom burden at two times of treatment. CONCLUSION: The study showed that both the MSAS-SF and the FACIT-Fatigue have good reliability and validity for use with patients with cancer in Uruguay. When used simultaneously, these instruments may provide a complete picture of the impact of cancer and its treatment on the patient's quality of life.
CONTEXT: Several instruments have been developed to assess the symptom burden and fatigue produced by cancer and its treatment. However, little research has been conducted in Latin American Spanish-speaking patients. OBJECTIVES: The aim of the study was to assess the psychometric properties of the Spanish versions of two commonly used patient-reported outcome measures, the Memorial Symptom Assessment Scale-Short Form (MSAS-SF), and the fatigue subscale of the Functional Assessment of Cancer Therapy-General (FACT-G), the FACIT-Fatigue. METHODS: A classic psychometric approach was followed to assess the reliability and validity of the instruments. Responsiveness to change and effect sizes were calculated. RESULTS: The translated version of the MSAS-SF proved to be comprehensible and easy to complete. Cronbach alpha reliability coefficients ranged from acceptable to excellent for the MSAS-SF subscale scores and the FACIT-Fatigue. There was evidence of convergent validity between the physical and the psychological subscales of the instruments. The MSAS-SF could discriminate among the known groups according to Eastern Cooperative Oncology performance status and level of anemia, and showed responsiveness to change of symptom burden at two times of treatment. CONCLUSION: The study showed that both the MSAS-SF and the FACIT-Fatigue have good reliability and validity for use with patients with cancer in Uruguay. When used simultaneously, these instruments may provide a complete picture of the impact of cancer and its treatment on the patient's quality of life.
Authors: Kelly A Hyland; Aasha I Hoogland; Brian D Gonzalez; Ashley M Nelson; Suzanne Lechner; Dinorah Martinez Tyson; Anna Barata; Maria F Gomez; Michael H Antoni; Brent Small; Cathy D Meade; Paul B Jacobsen; Heather S L Jim Journal: J Pain Symptom Manage Date: 2019-05-20 Impact factor: 3.612
Authors: Ryne Estabrook; David Cella; Fengmin Zhao; Judith Manola; Robert S DiPaola; Lynne I Wagner; Naomi B Haas Journal: Qual Life Res Date: 2018-03-05 Impact factor: 4.147
Authors: Roma Maguire; Lisa McCann; Grigorios Kotronoulas; Nora Kearney; Emma Ream; Jo Armes; Elisabeth Patiraki; Eileen Furlong; Patricia Fox; Alexander Gaiger; Paul McCrone; Geir Berg; Christine Miaskowkski; Antonella Cardone; Dawn Orr; Adrian Flowerday; Stylianos Katsaragakis; Andrew Darley; Simone Lubowitzki; Jenny Harris; Simon Skene; Morven Miller; Margaret Moore; Liane Lewis; Nicosha DeSouza; Peter T Donnan Journal: BMJ Date: 2021-07-21
Authors: Daniel Gutiérrez-Sánchez; Juan P Leiva-Santos; Rosa Sánchez-Hernández; Domingo Hernández-Marrero; Antonio I Cuesta-Vargas Journal: BMC Nephrol Date: 2016-11-18 Impact factor: 2.388
Authors: Alberto Soriano-Maldonado; Álvaro Carrera-Ruiz; David M Díez-Fernández; Alba Esteban-Simón; Mercedes Maldonado-Quesada; Nuria Moreno-Poza; María Del Mar García-Martínez; Celia Alcaraz-García; Rosa Vázquez-Sousa; Herminia Moreno-Martos; Antonio Toro-de-Federico; Nur Hachem-Salas; Eva Artés-Rodríguez; Manuel A Rodríguez-Pérez; Antonio J Casimiro-Andújar Journal: Medicine (Baltimore) Date: 2019-11 Impact factor: 1.817
Authors: Virginia Prieto-Gómez; María José Yuste-Sánchez; Javier Bailón-Cerezo; Helena Romay-Barrero; Irene de la Rosa-Díaz; Cristina Lirio-Romero; María Torres-Lacomba Journal: J Clin Med Date: 2022-01-05 Impact factor: 4.241